Adding pirfenidone to mycophenolate mofetil shows no significant improvement in lung function compared with mycophenolate alone, in a trial of systemic sclerosis-related interstitial lung disease.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/dual-therapy-combination-shows-no-added-benefit-systemic-2025a1000zsz?src=rss
Author :
Publish date : 2025-12-19 10:50:00
Copyright for syndicated content belongs to the linked Source.